Destination Therapy Post Approval Study Product Surveillance Registry Platform Addendum and Apogee

Age
99 years or below
Gender
All
participants needed
3
Location
1
Destination Therapy Post Approval Study Product Surveillance Registry Platform Addendum and Apogee

Brief description of study

The purpose of DT PAS PSR is to -Provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products for their intended use -To further confirm safety and effectiveness of the HVAD System when used as intended for DT, in real-world clinical practice The purpose of Apogee optional sub-study is to further enhance scientific understanding of the implant procedure, optimize blood pressure management, and anticoagulation/antiplatelet therapies.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Heart Failure
  • Age: 99 years or below
  • Gender: All

Prior Destiantion Therapy

Updated on 04 Aug 2024. Study ID: 832738
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research